Latest filing published 06 Oct 2026 for OCULAR THERAPEUTIX, INC, €63k.
Peter Kaiser discloses dealings in Ocular Therapeutix, Inc to SEC (Form 4). Between 2 October 2024 and 2 October 2026, the trades on record add up to 11 filings.
Sales make up the whole of the open-market record (9 sales, €327k). The rest of the record consists of 2 share grants. In 2026 alone, the filings show no purchases and 3 sales.
The latest filing, published on 6 October 2026, reports an open-market sale of €63k in Ocular Therapeutix, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations